Harry Palmin
Overview
Harry Palmin received an average of $609K in total compensation, including $330K in salary, at Opexa Therapeutics from 2017 to 2022.
2022Opexa TherapeuticsChief Financial Officer
2021Opexa TherapeuticsChief Operating Officer and Chief Financial Officer
2020Opexa TherapeuticsChief Operating Officer and Chief Financial Officer
2019Opexa TherapeuticsChief Operating Officer and Chief Financial Officer
2018Opexa TherapeuticsChief Operating Officer and Chief Financial Officer
2017Opexa TherapeuticsChief Financial Officer
Source: SEC filings on April 14, 2023, April 15, 2022, April 16, 2021, October 14, 2020, April 12, 2019, and April 9, 2018.
Related executives
We found 14 more executives who work or worked at Opexa Therapeutics.
Chris Schelling
Opexa Therapeutics
Chief Executive Officer
Adrian Quartel
Opexa Therapeutics
Chief Medical Officer
Jefferson Davis
Opexa Therapeutics
Chief Business Officer
Donald Joseph
Opexa Therapeutics
Chief Legal Officer
William FACP
Opexa Therapeutics
Chief Medical Officer
Neil Warma
Opexa Therapeutics
Chief Executive Officer
William Andrews
Opexa Therapeutics
Chief Medical Officer
Don Healey
Opexa Therapeutics
Chief Scientific Officer
News
Opexa Therapeutics CEO Chris Schelling's 2022 pay jumps 51% to $834K
April 14, 2023
Opexa Therapeutics Chief Business Officer Jefferson Davis receives $635K in 2021
April 15, 2022
Opexa Therapeutics CEO Chris Schelling's 2020 pay falls 54% to $676K
April 16, 2021
Opexa Therapeutics CEO Chris Schelling's 2019 pay jumps 167% to $1.5M
October 14, 2020
Opexa Therapeutics CEO Chris Schelling's 2018 pay slips 6% to $550K
April 12, 2019